Nanostructures as Radionuclide Carriers in Auger Electron Therapy

Area of Science:

• Nanomedicine
• Radiopharmaceutical Chemistry
• Oncology

Background:

• Nanoparticle-mediated drug delivery is a key strategy in modern cancer treatment.
• Radiopharmaceuticals are crucial for diagnosis and therapy, with a growing focus on radionuclide delivery systems.
• Auger electron radionuclides offer targeted cell killing potential but require precise delivery mechanisms.

Purpose of the Study:

• To review the development of nanostructures for cancer therapy using Auger electron radionuclides.
• To discuss various nanoconstructs, design principles, materials, and targeting strategies for effective delivery.
• To explore the potential of high-Z element nanoparticles and future clinical translation.

Main Methods:

• Literature review of nanostructures for Auger electron radionuclide therapy.
• Analysis of nanocarrier design, materials (inorganic and organic), and targeting vectors.
• Examination of high-Z element nanoparticles for photoelectron emission in radionuclide therapy.

Main Results:

• Various nanoconstructs have been developed as carriers for Auger electron emitters.
• Design principles, materials, and targeting vectors are crucial for overcoming delivery challenges.
• High-Z element nanoparticles show promise for radionuclide delivery and Auger electron emission.

Conclusions:

• Nanoparticle-based Auger electron radionuclide therapy holds significant promise for targeted cancer treatment.
• Further research is needed to address challenges and facilitate clinical translation.
• Optimized nanocarrier design and targeting are essential for therapeutic efficacy and safety.